These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
430 related items for PubMed ID: 18032539
1. Five-year outcome of a primary-care-based inception cohort of patients with inflammatory polyarthritis plus psoriasis. Morgan C, Lunt M, Bunn D, Scott DG, Symmons DP. Rheumatology (Oxford); 2007 Dec; 46(12):1819-23. PubMed ID: 18032539 [Abstract] [Full Text] [Related]
2. Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway. Nossent JC, Gran JT. Scand J Rheumatol; 2009 Dec; 38(4):251-5. PubMed ID: 19247847 [Abstract] [Full Text] [Related]
5. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis. Strober B, Teller C, Yamauchi P, Miller JL, Hooper M, Yang YC, Dann F. Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600 [Abstract] [Full Text] [Related]
6. Reduced disability at five years with early treatment of inflammatory polyarthritis: results from a large observational cohort, using propensity models to adjust for disease severity. Wiles NJ, Lunt M, Barrett EM, Bukhari M, Silman AJ, Symmons DP, Dunn G. Arthritis Rheum; 2001 May; 44(5):1033-42. PubMed ID: 11352234 [Abstract] [Full Text] [Related]
7. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies. Driessen RJ, Boezeman JB, Van De Kerkhof PC, De Jong EM. J Dermatolog Treat; 2009 May; 20(1):42-7. PubMed ID: 18649164 [Abstract] [Full Text] [Related]
12. Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study. Bongartz T, Coras B, Vogt T, Schölmerich J, Müller-Ladner U. Rheumatology (Oxford); 2005 Jan; 44(1):126-9. PubMed ID: 15479756 [Abstract] [Full Text] [Related]
13. Obesity in early adulthood as a risk factor for psoriatic arthritis. Soltani-Arabshahi R, Wong B, Feng BJ, Goldgar DE, Duffin KC, Krueger GG. Arch Dermatol; 2010 Jul; 146(7):721-6. PubMed ID: 20644032 [Abstract] [Full Text] [Related]
14. The NOAR Damaged Joint Count (NOAR-DJC): a clinical measure for assessing articular damage in patients with early inflammatory polyarthritis including rheumatoid arthritis. Bunn DK, Shepstone L, Galpin LM, Wiles NJ, Symmons DP. Rheumatology (Oxford); 2004 Dec; 43(12):1519-25. PubMed ID: 15316124 [Abstract] [Full Text] [Related]
15. Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis. Tey HL, Ee HL, Tan AS, Theng TS, Wong SN, Khoo SW. J Dermatol; 2010 May; 37(5):426-30. PubMed ID: 20536647 [Abstract] [Full Text] [Related]
16. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study. Mazzotta A, Esposito M, Costanzo A, Chimenti S. Am J Clin Dermatol; 2009 May; 10(5):319-24. PubMed ID: 19658444 [Abstract] [Full Text] [Related]
18. Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices. Gottlieb AB, Mease PJ, Mark Jackson J, Eisen D, Amy Xia H, Asare C, Stevens SR. J Dermatolog Treat; 2006 May; 17(5):279-87. PubMed ID: 17092858 [Abstract] [Full Text] [Related]
19. Prevalence of dermatophytosis in patients with rheumatoid arthritis. Bicer A, Tursen U, Cimen OB, Kaya TI, Ozisik S, Ikizoglu G, Erdogan C. Rheumatol Int; 2003 Jan; 23(1):37-40. PubMed ID: 12548440 [Abstract] [Full Text] [Related]
20. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Reich K, Krüger K, Mössner R, Augustin M. Br J Dermatol; 2009 May; 160(5):1040-7. PubMed ID: 19210498 [Abstract] [Full Text] [Related] Page: [Next] [New Search]